Mymetics

Mymetics Corporation is a US registered biotechnology company with its main office in Switzerland. Mymetics’ vision is to become the market leader in the development of new generation mucosal and virosome based vaccines. In 2009 Mymetics acquired Virosome Biologicals, a Leiden based company focused on virosome based vaccines.